Why do keloids hurt

Overview

Keloids are abnormal scar formations that extend beyond the boundaries of the original wound, characterized by excessive collagen deposition. First described in medical literature by French dermatologist Jean-Louis Alibert in 1806, keloids have been recognized since ancient times, with evidence from Egyptian medical texts dating to 1700 BCE. These raised, often painful scars affect approximately 10% of the global population, with significantly higher prevalence among people of African, Asian, and Hispanic descent (15-20% incidence) compared to Caucasians (less than 5%). Keloids most commonly develop between ages 10-30, with peak incidence during the second and third decades of life. They frequently occur on the chest, shoulders, earlobes, and cheeks, though they can form anywhere on the body. Unlike hypertrophic scars, which remain within wound boundaries and often improve over time, keloids continue growing for months or years and rarely regress spontaneously.

How It Works

Keloid pain results from multiple interacting mechanisms within the abnormal scar tissue. The primary cause is mechanical compression: keloids contain up to 20 times more collagen than normal scars, creating dense, fibrous tissue that presses directly on nerve endings and sensory receptors. This compression activates pain pathways through mechanosensitive ion channels. Additionally, keloids exhibit chronic inflammation with elevated levels of inflammatory mediators like substance P, prostaglandins, and cytokines (particularly TGF-β), which sensitize nociceptors and lower pain thresholds. The scar's vascular component contributes through ischemia-reperfusion injury, where compromised blood flow followed by sudden restoration creates oxidative stress that activates pain receptors. Keloids also develop abnormal nerve fiber proliferation (neurogenesis) within the scar matrix, creating hypersensitive neural networks. Pain typically worsens during active growth phases when collagen production peaks, and responds to mechanical stimuli like pressure, friction, or temperature changes that further compress or irritate the scar tissue.

Why It Matters

Keloid pain significantly impacts quality of life, with approximately 30% of patients reporting severe pain that interferes with daily activities, sleep, and emotional well-being. The chronic nature of keloid pain (often lasting years or decades) contributes to psychological distress, with studies showing 40-60% of keloid patients experience depression or anxiety related to their condition. Pain management represents a major clinical challenge, as traditional analgesics often provide limited relief, leading to substantial healthcare costs estimated at $2-4 billion annually in the U.S. alone. Understanding keloid pain mechanisms has driven development of targeted treatments like cryotherapy combined with intralesional corticosteroids (showing 50-80% pain reduction in clinical trials), laser therapy, and emerging biological agents that specifically address neurogenic inflammation. Beyond individual suffering, keloid pain has socioeconomic implications, particularly in high-prevalence populations where it can limit occupational activities and require repeated medical interventions.